These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 31037153)
21. [Blockade of programmed death-ligand 1 attenuates indirect acute lung injury in mice through targeting endothelial cells but not epithelial cells]. Sun B; Li X; Zheng G; Dong T; Li Y; Li H; Yan Y; Bai J; Xu S Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jan; 31(1):37-43. PubMed ID: 30707867 [TBL] [Abstract][Full Text] [Related]
22. Programmed cell death receptor ligand 1 modulates the regulatory T cells' capacity to repress shock/sepsis-induced indirect acute lung injury by recruiting phosphatase SRC homology region 2 domain-containing phosphatase 1. Tang L; Bai J; Chung CS; Lomas-Neira J; Chen Y; Huang X; Ayala A Shock; 2015 Jan; 43(1):47-54. PubMed ID: 25057927 [TBL] [Abstract][Full Text] [Related]
23. The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8 David P; Megger DA; Kaiser T; Werner T; Liu J; Chen L; Sitek B; Dittmer U; Zelinskyy G Front Immunol; 2019; 10():54. PubMed ID: 30804928 [TBL] [Abstract][Full Text] [Related]
24. Identification of B7-H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis. Huang X; Chen Y; Chung CS; Yuan Z; Monaghan SF; Wang F; Ayala A J Immunol; 2014 Feb; 192(3):1091-9. PubMed ID: 24379123 [TBL] [Abstract][Full Text] [Related]
25. Kupffer cells potentiate liver sinusoidal endothelial cell injury in sepsis by ligating programmed cell death ligand-1. Hutchins NA; Wang F; Wang Y; Chung CS; Ayala A J Leukoc Biol; 2013 Nov; 94(5):963-70. PubMed ID: 23766529 [TBL] [Abstract][Full Text] [Related]
26. Effect of PD-1: PD-L1 in Invariant Natural Killer T-Cell Emigration and Chemotaxis Following Sepsis. Young JS; Heffernan DS; Chung CS; Kettenmann ML; Young WA; Guillen VS; Cioffi WG; Ayala A Shock; 2016 May; 45(5):534-9. PubMed ID: 26717105 [TBL] [Abstract][Full Text] [Related]
27. Effector T cell function rather than survival determines extent and duration of hepatitis in mice. Vo M; Holz LE; Wong YC; English K; Benseler V; McGuffog C; Azuma M; McCaughan GW; Bowen DG; Bertolino P J Hepatol; 2016 Jun; 64(6):1327-38. PubMed ID: 26924452 [TBL] [Abstract][Full Text] [Related]
28. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1. Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246 [TBL] [Abstract][Full Text] [Related]
29. Lactate up-regulates the expression of PD-L1 in kidney and causes immunosuppression in septic Acute Renal Injury. Xu J; Ma X; Yu K; Wang R; Wang S; Liu R; Liu H; Gao H; Yu K; Wang C J Microbiol Immunol Infect; 2021 Jun; 54(3):404-410. PubMed ID: 31727535 [TBL] [Abstract][Full Text] [Related]
30. PD-L1 Ameliorates Murine Acute Graft-Versus-Host Disease by Suppressing Effector But Not Regulatory T Cells Function. Tang L; Ma S; Gong H; Wang J; Xu Y; Wu D; Sun A Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):179-187. PubMed ID: 30927016 [TBL] [Abstract][Full Text] [Related]
31. Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice. Lau J; Cheung J; Navarro A; Lianoglou S; Haley B; Totpal K; Sanders L; Koeppen H; Caplazi P; McBride J; Chiu H; Hong R; Grogan J; Javinal V; Yauch R; Irving B; Belvin M; Mellman I; Kim JM; Schmidt M Nat Commun; 2017 Feb; 8():14572. PubMed ID: 28220772 [TBL] [Abstract][Full Text] [Related]
32. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade. Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349 [TBL] [Abstract][Full Text] [Related]
33. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy. Goto T; Nishida T; Takagi E; Miyao K; Koyama D; Sakemura R; Hanajiri R; Watanabe K; Imahashi N; Terakura S; Murata M; Kiyoi H J Immunother; 2016 Oct; 39(8):306-15. PubMed ID: 27548033 [TBL] [Abstract][Full Text] [Related]
34. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. Shen L; Jin Y; Freeman GJ; Sharpe AH; Dana MR J Immunol; 2007 Sep; 179(6):3672-9. PubMed ID: 17785803 [TBL] [Abstract][Full Text] [Related]
35. Zinc dyshomeostasis during polymicrobial sepsis in mice involves zinc transporter Zip14 and can be overcome by zinc supplementation. Wessels I; Cousins RJ Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G768-78. PubMed ID: 26272258 [TBL] [Abstract][Full Text] [Related]
37. Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8 Li J; Lee Y; Li Y; Jiang Y; Lu H; Zang W; Zhao X; Liu L; Chen Y; Tan H; Yang Z; Zhang MQ; Mak TW; Ni L; Dong C Immunity; 2018 Apr; 48(4):773-786.e5. PubMed ID: 29625896 [TBL] [Abstract][Full Text] [Related]
38. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503 [TBL] [Abstract][Full Text] [Related]
39. Atezolizumab alleviates the immunosuppression induced by PD‑L1‑positive neutrophils and improves the survival of mice during sepsis. Chen J; Chen R; Huang S; Zu B; Zhang S Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33655320 [TBL] [Abstract][Full Text] [Related]
40. Bone marrow mesenchymal stromal cells attenuate liver allograft rejection may via upregulation PD-L1 expression through downregulation of miR-17-5p. Chen Q; Zhou R; Zhang Y; Zhu S; Xiao C; Gong J; Li K; Tang H; Sun C; Zhang J Transpl Immunol; 2018 Dec; 51():21-29. PubMed ID: 30092337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]